Bowel (colorectal) cancer, Pancreatic cancer
Results
Phase 1
This trial looked at a drug called plerixafor for people with pancreatic cancer or bowel cancer that has spread.
The trial was open for people to join between 2015 and 2018. The team published the results in 2020.
Recruitment start: 29 June 2015
Recruitment end: 14 December 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Duncan Jodrell
Cambridge Experimental Cancer Medicine Centre (ECMC)
Cambridge Clinical Trials Unit
Cambridge NIHR Cambridge Biomedical Research Centre
Cancer Research UK – Cambridge Institute
Stand Up to Cancer (SU2C)
The Lustgarten Foundation
University of Cambridge
Last reviewed: 14 September 2021
CRUK internal database number: 12721
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
